The IBTN Executive Committee currently serves at the helm of the IBTN. Its members are all experts in their own right in various subfields of behavioural science. They contribute actively to the IBTN’s current projects, including the organization of the annual conference and the new SPOR initiative through which the IBTN Summer School is offered.
The founding members of the IBTN were drawn from a variety of areas and countries. These international experts have many years of experience in developing and delivering behavioural trials and a number of them have been involved in some of the largest trials in our field. They have pulled together this expertise to create the IBTN and through this work hope to improve the quality and quantity of behavioural interventions and trials.
Interested in joining our group? Contact us
Simon L. Bacon, PhD (co-lead)
Dr. Simon Bacon, co-Director of the Montreal Behavioural Medicine Centre and Director of the Centre de Readaptation Jean-Jacques-Gauthier, has had extensive training in the delivery of behavioural randomised controlled trials and has been a PI and co-I on 12 different studies involving behavioural interventions, including exercise, weight management, stress management, and motivational interviewing. In addition, he has several years in generating national recommendations through his work with the Canadian Hypertension Education Program (CHEP: he has been a member of the last 5 recommendation panels), where he is currently the chair of the lifestyles sub-committee. Finally, Dr. Bacon has organised several knowledge translation events, including Café Scientifiques, where he has brought a number of different stakeholders together to discuss key topics and issues, for example, trying to create a common dialogue between researchers and the media to improve health innovation reporting.
Kim Lavoie, PhD (co-lead)
Gregory Ninot, PhD (co-lead)
Dr. Grégory Ninot is a Professor at the University of Montpellier (France). He leads the CEPS Platform, which is dedicated to improving the methodology of behavioral and non-pharmalogical trials. Dr. Ninot plays a critical coordination role in the development of the quality of these studies in Europe. He is involved in several clinical trials and meta-analyses testing the efficacy of exercise programs, e-health solutions, psychotherapy or disease management education methods mainly in patients with respiratory disease or cancer. He has published over one hundred articles and more than a dozen books on the subject. He writes a blog to raise public awareness of randomized controlled trials, with the ultimate goal of improving care for chronic disease patients.
Jean Bourbeau, PhD
Dr. Jean Bourbeau, Respirologist and Professor in the departments of Medicine and Epidemiology & Biostatistics at McGill University, is the director of the McConnell Centre of Innovative Medicine (CIM) of the Research Institute of the MUHC (RIMUHC) and the Pulmonary Rehabilitation Unit at the Montreal Chest Institute of the McGill University Health Centre (MUHC). His areas of research and expertise are in COPD, rehabilitation, and disease self-management. He has a particular interest in behavioural Randomized Clinical Trials, including five noteworthy major multicentre RCTs of non-pharmacological interventions building evidence based for use in clinical practice (self-management COPD/FRSQ, home rehabilitation/CIHR, COMET/Airliquid, PHYSACTO/BI, and PROPEL/NHLBI). His work has not only had impact in research but also in clinical practice and the public domain (e.g., Living Well with COPD). In addition, Dr. Bourbeau chairs the COPD axis of the Health Respiratory Network of the FRQS, and serves on the board of the CTS of which he was past president. He is on the scientific committee of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and leading/co-leading guidelines/position statements in COPD (CTS, Chest, ATS/ERS, and GOLD). Through his leadership Dr. Bourbeau will be able provide additional knowledge translation opportunities to advance the work of the IBTNetwork.
Susan Czajkowski, PhD
Dr. Susan Czajkowski, Chief of the Health Behaviors Research Branch (HBRB) of the National Cancer Institute (NCI), is an expert on psychosocial and behavioral risk factors for disease, including the role of social support and depression in disease risk and recovery; the development and testing of interventions for behavioral risk factors such as obesity, physical inactivity, adverse diets, and non-adherence to medical regimens; and the assessment of health-related quality of life and psychosocial functioning in patients with chronic diseases. She has managed several research initiatives involving improvement of adherence to lifestyle and medical therapies in patient populations, including minority patients and the medically underserved and was project officer for the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients Study, the largest multicenter clinical trial to evaluate the effects of treating depression and low social support in heart attack patients. As lead project officer for the NIH-funded Obesity-Related Behavioral Intervention Trials (ORBIT) network, Dr. Czajkowski and Dr. Lynda Powell led the development of the ORBIT model for preventing and treating chronic diseases. Dr. Czajkowski is a fellow in the Society of Behavioral Medicine, and recently served as President of the Academy of Behavioral Medicine Research.
Kenneth Freedland, PhD
Dr. Kenneth Freedland, Professor of Psychiatry and Psychology, Washington University School of Medicine, is an expert in the behavioural treatment of depression and related problems in medically ill patients. He has been the principal investigator or a co-investigator on a number of single-site and multicenter trials of treatments for depression in patients with coronary heart disease, heart failure, diabetes, lung disease, or other conditions. For example, Dr. Freedland was a co-investigator and clinical supervisor for the multicenter Enhancing Recovery in Coronary Heart Disease (ENRICHD), a co-investigator and assessment core leader for the multicenter CODIACS Vanguard trial, and a co-investigator and clinical supervisor for the multicenter INSPIRE trial of stress management for lung transplant candidates. He has also been the P.I. on several behavioural intervention trials, including an ongoing RCT of a cognitive-behavioural intervention for depression and self-care in patients with heart failure. In addition, Dr. Freedland is a founding fellow of the Academy of Cognitive Therapy (ACT) and an ACT-certified cognitive therapy trainer, an instructor in clinical trial methodology on the faculty of the National Institutes of Health annual Summer Institute on Randomized Behavioural Clinical Trials, and the author of a number of published articles and book chapters on behavioural trial methodology. He has a particular interest in the selection and design of control groups for behavioural trials.
Susan Michie, PhD
Dr. Susan Michie is Professor of Health Psychology at University College London (UCL) and Director of its Centre for Behaviour Change and its Health Psychology Research Group. She is Principal Investigator of the Human Behaviour-Change Project. She is a chartered clinical and health psychologist, whose research focuses on behaviour change in relation to health: how to understand it theoretically and apply theory to intervention development and evaluation, and to evidence synthesis. This is conducted in the domains of risky and preventive behaviours amongst the general population (e.g. smoking, alcohol use, preparing for pandemic flu), managing illness (e.g. medication adherence), and professional practice and implementation (e.g. hand-hygiene amongst hospital staff). Her work includes developing and evaluating digital interventions and investigating the fidelity of delivery of interventions. Her research develops methods to advance the study of behaviour change, including frameworks such as the Behaviour Change Wheel and the Theoretical Domains Framework, and specifying intervention content using taxonomies of behaviour change techniques (BCT Taxonomy v1). Two relevant books she has authored are The Behaviour Change Wheel Guide to Designing Interventions and The ABC of Behaviour Change Theories.
Paul Montgomery, PhD
Dr. Paul Montgomery is Professor of Social Interventions at the University of Birmingham (UK) and leads on the development of the CONSORT-SPI, a reporting guideline for randomised trials of complex psychological and social interventions. His research focuses on improving our understanding of what interventions are effective in tackling complex psychological, social, and health problems and GRADE- CI a tool to assess a body of evidence for systematic reviews. His academic work spans a range of issues, from chronic sleep problems to HIV/AIDS, and integrates the use of several high-quality methodological approaches, many of which have not been traditionally applied in the social sciences. This work falls under three broad categories: (1) Methodology of Psycho-Social Intervention, (2) Nutrition, and (3) Behavioural Interventions. This work has been widely published and he has received funding from multiple sources. A social worker by training, Paul maintains a clinical practice on top of his academic work, where he specialises in Brief Intervention and Cognitive Behavioural techniques for depression, anxiety and insomnia, and treats both adults and adolescents.
Lynda Powell, PhD
Dr. Lynda Powell is the Charles J. and Margaret Roberts Professor of Preventive Medicine, Medicine (Cardiology), Behavioral Sciences, and Pharmacology and Chairman, Department of Preventive Medicine and Rush University Medical Center. Her research specializes in the behavioural treatment development and behavioural randomized clinical trials to promote cardiometabolic health. Dr. Powell has been the Principal Investigator of six major randomized behavioural clinical trials and a founding faculty member and former Co-Director of the NIH-OBSSR Summer Institute on Behavioral Clinical trials, now in its seventeenth year. Dr. Powell was a Principal Investigator of the NIH-funded ORBIT network which included seven sites all of whom were in the process of developing behavioural interventions for obesity and created the ORBIT model for behavioural treatment development from the experiences of the ORBIT.
Bonnie Spring, PhD
Dr. Bonnie Spring, Professor of Preventive Medicine, Psychology, and Psychiatry at Northwestern University and Director of the Center for Behavior and Health of its Institute for Public Health and Medicine, is recognized internationally for her research on interventions to improve risk behaviors for chronic disease. Her research on smoking, physical inactivity, and obesity has been funded continuously since 1976 primarily by grants from the NIH (NHLBI, NIDDK, NCI, NIMH), American Heart Association, American Cancer Society, and Department of Veterans Affairs. She has been PI of a number of clinical trials fostering smoking cessation and reduction of weight gain via pharmacological and behavioral treatments. A NIDA-funded effectiveness trial that delivers her intervention using the nationwide tobacco telephone quit lines is currently ongoing. She was also founding editor and editor-in-chief of Translational Behavioral Medicine: Practice, Policy, Research. She chairs the NIH PRDP standing study section, previously chaired the American Psychological Association’s Board of Scientific Affairs and the American Heart Association’s Health Behavior Change Committee. She is PI of several trials using technology-supported interventions to foster change in multiple diet and activity behaviors or weight loss. Her current trials implement novel research designs adapted from engineering science to optimize and increase the efficiency of behavioral intervention development. Her NIH-funded on-line learning modules on evidence-based practice (www.ebbp.org) and on team science (www.teamscience.net) are freely accessible online.
Molly Byrne, PhD
Dr. Molly Byrne is a Professor of Health Psychology at the National University of Ireland, Galway. In 2014 she was awarded a Health Research Board (HRB, Ireland) Research Leadership Award (2014-2019) to establish and direct the Health Behaviour Change Research Group (HBCRG). This group aims to improve population health by developing and promoting an evidence-based behavioural science approach to health behaviour change interventions. The team are interested in developing novel approaches to increase the implementation and impact of behaviour change interventions, with particular interest in participatory approaches to research involving patients and public. The team are currently running a number of intervention development studies, pilot trials of interventions and definitive intervention trials. Studies are focused on areas including: self-management among young adults with Type 1 Diabetes; attendance at structured education programmes for people with Type 2 Diabetes; delivery of sexual counselling within hospital cardiac rehabilitation; interventions to increase physical activity among overweight pregnant women and interventions to promote healthy infant feeding delivered in primary care
Justin Presseau, PhD
Dr. Justin Presseau is a scientist and health psychologist at the Ottawa Hospital Research Institute and Assistant Professor in the School of Epidemiology, Public Health and Preventive Medicine at the University of Ottawa. He holds a Ph.D. in Psychology from the University of Aberdeen (UK). His research draws upon theories and approaches from health psychology and behavioural medicine to develop and evaluate interventions focused on changing healthcare professional behaviours and health behaviours of patients and the public.
Tavis Campbell, PhD
Dr. Tavis Campbell is a Professor of Clinical Psychology and Oncology at the University of Calgary, where he also holds the position of Director of Clinical training. He obtained his Ph.D from McGill University and completed a Postdoctoral Fellowship at Duke University Medical Centre. His research interests involve identifying and understanding the bio-behavioral mechanisms involved in the development, progression, and management of chronic diseases, such as hypertension, cancer and insomnia. Dr. Campbell has published results from several behavior-based RCTs in the areas of cancer, pain, and chronic disease management, including the i-can sleep trial targeting insomnia in cancer survivors. In addition, he is actively involved in the Canadian Hypertension Education Program (CHEP) and is Chair of the Adherence Committee and an active member of the Knowledge Translation Committee at Hypertension Canada. Finally, Dr.Campbell is regularly sought out by a variety of healthcare professionals (e.g., physicians, rheumatologists, nurses, dermatologists) to deliver workshops with a focus on motivating health behavior change and improving patient-provider communication.
- Dr. Isabelle Boutron, PhD, Professor of Clinical Epidemiology at the Université Paris Descartes and researchers at the INSERM U738 email@example.com
- Dr. Tim Caulfield, PhD, Canada Research Chair in Health Law, Trudeau Fellow and Professor at the Faculty of Law and School of Public Health and Policy, and Research Director of the University of Alberta Faculty of Law’s Health Law Institute firstname.lastname@example.org
- Dr. Karina Davidson, PhD, Professor of Behavioral Medicine in Medicine and Psychiatry at Columbia College of Physicians and Surgeons and Director of the Center for Behavioral & Cardiovascular Health email@example.com
- Dr. Gaston Godin, PhD, Professor Emeritus at Université Laval firstname.lastname@example.org
- Dr. David Moher, PhD, Senior Scientist at the Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI) email@example.com
- Dr. Lise Rochaix, PhD, full time member of the executive board of the French national health authority (HAS – Haute Autorité de Santé) and chairs the economics and public health assessment committee (CEESP – Commission d’Evaluation Economique et de Santé Publique) firstname.lastname@example.org
- Dr. David Secko, PhD, Associate Professor of Journalism at Concordia University email@example.com
- Dr. Stan Shapiro, PhD, Professor in the Department of Epidemiology and Biostatistics, McGill University, and a consultant to the Randomized Clinical Trial Unit at the Montreal Jewish General Hospital firstname.lastname@example.org